1. Research interest

Cardiothoracic surgery; Extracorporeal membrane oxygenation

2. Educational Background

1981.09～1986.07The Fourth Military Medical University, Clinical Medicine, Bachelor's degree

1989.09～1991.07The Fourth Military Medical University, Cardiothoracic surgery , Master's degree

1991.08～1994.07The Fourth Military Medical University, Cardiothoracic surgery , Ph.D& M.D

2001.10～2002.11Humboldt-University zu Berlin,department of cardiac surgery, postdoctor

3.Work Experience

1986.07～1987.02 Go to the frontline on the Mountain Lao in Yunnan, chirugeon

1987.03～1989.07 The Fourth Military Medical University, Xijing Hospital, Resident physician, teaching assistant

1994.07～1997.07The Fourth Military Medical University, Xijing Hospital,Attending physician and lecturer

1997.07～2003.08 The Fourth Military Medical University, Xijing Hospital,Associate professor, associate chief physician

2003.09～2005.06The Fourth Military Medical University, Professor, Chief physician

2005.06～2014.03Tianjin Third Central Hospital,Vice president of hospital, Chief physician

2014.03～NOW Tianjin Third Central Hospital, president of hospital, Chief physician

4.Major Professional memberships

Tianjin institute of biomedical engineeringpresident

Tianjin medical doctor associationVice president

5. Major Projects

①．Tianjin technology support plan from science and technology commission science “Study on risk assessment system of acute cardiopulmonary failure with ECMO”

②Tianjin technology support plan from science and technology commission science “Study on risk factors and gene polymorphism of chronic stable coronary heart disease for early warning”

③Tianjin key discipline project“Mechanism and clinical study of left heart related pulmonary hypertension”

④Major issues from Tianjin science and technology commission “Standardized treatment of end-stage heart disease”

⑤Tianjin technology support plan from science and technology commission science“Experimental and clinical application of heparin coated pipeline for artificial cardiopulmonary support system”

⑥The fourth batch of major independent innovation industrialization projects in Tianjin”Development of new heparin coating materials and ECMO consumable products”

⑦Tianjin natural science foundation”Umbilical cord mesenchymal stem cells and umbilical cord blood CD34+ were combined to treat myocardial infarction”

6. Major Academic papers published

1. Fan YangTong Li*Zhihuan DongRui Mi, MicroRNA‐410 is involved in mitophagy after cardiac ischemia/reperfusion injury by targeting high‐mobility group box 1 protein; Journal of Cellular Biochemistry;2018 , 119 (2)2427-2439

2. Yue Zhao,*, Yi Li,*, Peiyi Luo, Yingtang Gao, Junyao Yang, Ka-Hou Lao, Gang Wang, Gillian Cockerill, Yanhua Hu, Qingbo Xu, Tong Li1, & Lingfang Zeng； XBP1 splicing triggers miR-150 transfer from smooth muscle cellsto endothelial cells via extracellularvesicles；Scientific Reports；2016 , 6 :28627

3. Yun-yun Wang, Tong Li, Ying-wu Liu, Yu Wang, Xiao-min Hu, Wen-qing Gao, Peng Wu, Xin Li,

Wen-jin Peng, Wei Gao, Guang-dong Yu, and Bo-jiang Liu；Ischemic Postconditioning Before Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction Reduces Contrast-induced Nephropathy and Improves Long-term Prognosis，Archives of Medical Research 47 (2016) 483-488，DOI：10.1016/j.arcmed.2016.10.001

4. Lei Huang,Tong Li,Lei Xu,Xiao-min Hu,Da-wei Duan,Zhi-bo Li,Xin-jing Gao,Jun Li,Peng Wu,Ying-Wu Liu，Extracorporeal Membrane Oxygenation Outcomes in Acute Respiratory Distress Treatment: Case Study in a Chinese Referral Center，Med Sci Monit，2017; 23: 741-750，DOI: 10.12659/MSM.900005

5. Lei Huang1, Tong Li2, Ying-Wu Liu2, Lei Zhang3, Zhi-Huan Dong1, Shu-Ye Liu3, Ying-Tang Gao4，Plasma Metabolic Profile Determination in Young ST‑segment Elevation Myocardial Infarction Patients with Ischemia and Reperfusion: Ultra‑performance Liquid Chromatography and Mass Spectrometry for Pathway Analysis，Chinese Medical Journal ¦ May 5, 2016 ¦ Volume 129 ¦ Issue 9，DOI:10.4103/0366-6999.180527

6. Wenqing Gao1*, Tong Li1, Meili Yu2*, Xiaomin Hu1, Dawei Duan1, Tingting Lin3*Preparation of sustained-release composite coating formed by dexamethasone and oxidated sodium alginate，Int J Clin Exp Med 2014;7(9):3053-3061，

7. Wang Yunyun1, Li Tong1*, Liu Yingwu1, Liu Bojiang1, Wang Yu1, Hu Xiaomin1, Li Xin1, Peng Wenjin1 and JinFang Li2，Analysis of risk factors of ST-segment elevation myocardial infarction in young patients，BMC Cardiovascular Disorders 2014, 14:179、

8. Tong Li • Qunxing Ma • Meng Ning •Yue Zhao • Yuelong Hou，Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34+ cells in a rabbit model of myocardial infarction，Mol Cell Biochem，DOI 10.1007/s11010-013-1874-5

9. Li Tong, Huang Lei, Duan Dawei, Hu Xiaomin, Wu Peng and Zhang Qiang，Acute graft occlusion caused by heparin resistance during on-pump coronary artery bypass graft surgery，Chinese Medical Journal 2014;127 (3)，DOI: 10.3760/cma.j.issn.0366-6999.20132068

10. Wenqing Gao1,2*, Tingting Lin1*, Tong Li2, Meili Yu3, Xiaomin Hu2, Dawei Duan2，Sodium alginate/heparin composites on PVC surfaces inhibit the thrombosis and platelet adhesion: applications in cardiac surgery，Int J Clin Exp Med 2013;6(4):259-268，